We are here to beat cancer by going after important cancer targets that drive this terrible disease. 

We are a group of experienced drug hunters who put proteins in context to develop conditional inhibitors that selectively modulate proteins in their functional state. 

We are not daunted when cancer targets appear elusive. Our goal is to stop cancer-causing proteins in their tracks with small molecules that deliver a knock-out punch. 

We are moving forward with urgency, because we know our work has the potential to transform lives and patients cannot wait.